| Report ID | 173505 |
| Drug Identification Number | 02494264 |
| Brand name | TARO-BUDESONIDE |
| Common or Proper name | BUDESONIDE |
| Company Name | TARO PHARMACEUTICALS INC |
| Market Status | MARKETED |
| Active Ingredient(s) | BUDESONIDE |
| Strength(s) | 0.125MG |
| Dosage form(s) | SUSPENSION |
| Route of administration | INHALATION |
| Packaging size | 2 |
| ATC code | R03BA |
| ATC description | OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2022-04-14 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2026-03-02 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 130 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
| Company contact information |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v70 | 2026-03-02 | French | Compare |
| v69 | 2026-03-02 | English | Compare |
| v68 | 2026-02-23 | French | Compare |
| v67 | 2026-02-23 | English | Compare |
| v66 | 2026-02-06 | French | Compare |
| v65 | 2026-02-06 | English | Compare |
| v64 | 2025-12-05 | French | Compare |
| v63 | 2025-12-05 | English | Compare |
| v62 | 2025-11-11 | French | Compare |
| v61 | 2025-11-11 | English | Compare |
| v60 | 2025-10-06 | French | Compare |
| v59 | 2025-10-06 | English | Compare |
| v58 | 2025-09-15 | French | Compare |
| v57 | 2025-09-15 | English | Compare |
| v56 | 2025-07-07 | French | Compare |
| v55 | 2025-07-07 | English | Compare |
| v54 | 2025-06-04 | French | Compare |
| v53 | 2025-06-04 | English | Compare |
| v52 | 2025-05-20 | French | Compare |
| v51 | 2025-05-20 | English | Compare |